Less may be enough: a transplant-free future for low risk relapsed Hodgkin lymphoma
Open Access
- 1 August 2025
- journal article
- Published by AME Publishing Company in Translational Pediatrics
- Vol. 14 (8) , 1741-1745
Abstract
Less may be enough: a transplant-free future for low-risk relapsed Hodgkin lymphomaKeywords
This publication has 26 references indexed in Scilit:
- A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphomaBone Marrow Transplantation, 2015
- PET-Directed Therapy for Hodgkin's LymphomaNew England Journal of Medicine, 2015
- PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 studyThe Lancet Oncology, 2015
- Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate-Risk Hodgkin Lymphoma: A Report From the Children's Oncology Group Study AHOD0031Journal of Clinical Oncology, 2014
- Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma - results of the UK HD3 relapse treatment strategyBritish Journal of Haematology, 2014
- Stratification of treatment intensity in relapsed pediatric Hodgkin lymphomaPediatric Blood & Cancer, 2013
- Long-Term Effects of High-Dose Chemotherapy and Radiation for Relapsed and Refractory Hodgkin's LymphomaJournal of Clinical Oncology, 2008
- Salvage Therapy of Progressive and Recurrent Hodgkin’s Disease: Results From a Multicenter Study of the Pediatric DAL/GPOH-HD Study GroupJournal of Clinical Oncology, 2005
- Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trialThe Lancet, 2002
- Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trialThe Lancet, 1993